相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Whole-genome sequencing of East Asian lung cancers reveals new germline pathogenic variants
Semanti Mukherjee et al.
CANCER CELL (2022)
Efferocytosis in atherosclerotic lesions: Malfunctioning regulatory pathways and control mechanisms
Amir Tajbakhsh et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Hepatic regulation of VLDL receptor by PPAR beta/delta and FGF21 modulates non-alcoholic fatty liver disease
Mohammad Zarei et al.
MOLECULAR METABOLISM (2018)
Ligand-Dependent Interaction of PPARδ With T-Cell Protein Tyrosine Phosphatase 45 Enhances Insulin Signaling
Taesik Yoo et al.
DIABETES (2018)
Intestinal PPARδ protects against diet-induced obesity, insulin resistance and dyslipidemia
Marcela Doktorova et al.
SCIENTIFIC REPORTS (2017)
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
David Jones et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)
PPARδ Promotes Running Endurance by Preserving Glucose
Weiwei Fan et al.
CELL METABOLISM (2017)
Immunometabolism governs dendritic cell and macrophage function
Luke A. J. O'Neill et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Pathophysiology and Mechanisms of Nonalcoholic Fatty Liver Disease
Joel T. Haas et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Varman T. Samuel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Transcriptional control of physiological and pathological processes by the nuclear receptor PPARβ/δ
Nguan Soon Tan et al.
PROGRESS IN LIPID RESEARCH (2016)
Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease
Manuel Vazquez-Carrera
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Marja-Riitta Taskinen et al.
ATHEROSCLEROSIS (2015)
PPAR-beta/delta activation promotes phospholipid transfer protein expression
Khouloud Chehaibi et al.
BIOCHEMICAL PHARMACOLOGY (2015)
Establishing the Role of PPARβ/δ in Carcinogenesis
Jeffrey M. Peters et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
Insulin resistance and impaired adipogenesis
Birgit Gustafson et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2015)
PPARα Is Required for PPAδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice
Wojciech G. Garbacz et al.
PPAR RESEARCH (2015)
Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization
Abhishek K. Jha et al.
IMMUNITY (2015)
IL-6 in diabetes and cardiovascular complications
Dan Qu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor
Yan Yang et al.
CELLULAR SIGNALLING (2014)
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Kathleen R. Markan et al.
DIABETES (2014)
PPARβ/δ prevents endoplasmic reticulum stress-associated inflammation and insulin resistance in skeletal muscle cells through an AMPK-dependent mechanism
Laia Salvado et al.
DIABETOLOGIA (2014)
PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats
K. Sodhi et al.
INTERNATIONAL JOURNAL OF OBESITY (2014)
PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity
Lazar A. Bojic et al.
JOURNAL OF LIPID RESEARCH (2014)
Targeting the pancreatic β-cell to treat diabetes
Amedeo Vetere et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
PHYSIOLOGICAL FUNCTIONS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR β
Jaap G. Neels et al.
PHYSIOLOGICAL REVIEWS (2014)
Regulation of energy metabolism by long-chain fatty acids
Manabu T. Nakamura et al.
PROGRESS IN LIPID RESEARCH (2014)
Peroxisome proliferator-activated receptor delta and cardiovascular disease
Ewa Ehrenborg et al.
ATHEROSCLEROSIS (2013)
Desnutrin/ATGL Activates PPARδ to Promote Mitochondrial Function for Insulin Secretion in Islet β Cells
Tianyi Tang et al.
CELL METABOLISM (2013)
A comparative perspective on lipid storage in animals
Kivanc Birsoy et al.
JOURNAL OF CELL SCIENCE (2013)
Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications
Norbert Stefan et al.
LANCET DIABETES & ENDOCRINOLOGY (2013)
Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Human Macrophage Foam Cell Formation and the Inflammatory Response Induced by Very Low-Density Lipoprotein
Lazar A. Bojic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Lipid Effects of Peroxisome Proliferator-Activated Receptor-δ Agonist GW501516 in Subjects With Low High-Density Lipoprotein Cholesterol Characteristics of Metabolic Syndrome
Eric J. Olson et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia
Yun-Jung Choi et al.
ATHEROSCLEROSIS (2012)
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Christopher K. Glass et al.
CELL METABOLISM (2012)
The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells
L. Serrano-Marco et al.
DIABETOLOGIA (2012)
Peroxisome proliferator-activated receptor δ agonist attenuates hepatic steatosis by anti-inflammatory mechanism
Mi Young Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2012)
Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist
Keiko Iwaisako et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
GW501516-activated PPARβ/δ promotes liver fibrosis via p38-JNK MAPK-induced hepatic stellate cell proliferation
Radina Kostadinova et al.
CELL AND BIOSCIENCE (2012)
Peroxisome proliferator-activated receptors and cancer: challenges and opportunities
Jihan Youssef et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Activation of Peroxisome Proliferator-Activated Receptor-β/-δ (PPAR-β/-δ) Ameliorates Insulin Signaling and Reduces SOCS3 Levels by Inhibiting STAT3 in Interleuldn-6 Stimulated Adipocytes
Lucia Serrano-Marco et al.
DIABETES (2011)
The PPARβ/δ Activator GW501516 Prevents the Down-Regulation of AMPK Caused by a High-Fat Diet in Liver and Amplifies the PGC-1α-Lipin 1-PPARα Pathway Leading to Increased Fatty Acid Oxidation
Emma Barroso et al.
ENDOCRINOLOGY (2011)
PPARβ/δ Activation Induces Enteroendocrine L Cell GLP-1 Production
Mehdi Daoudi et al.
GASTROENTEROLOGY (2011)
The nuclear receptor PPARβ/δ programs muscle glucose metabolism in cooperation with AMPK and MEF2
Zhenji Gan et al.
GENES & DEVELOPMENT (2011)
Pharmacological Activation of Peroxisome Proliferator-activated Receptor δ Improves Insulin Resistance and Hepatic Steatosis in High Fat Diet-induced Diabetic Mice
H. -T. Wu et al.
HORMONE AND METABOLIC RESEARCH (2011)
Role of Peroxisome Proliferator-activated Receptor δ/β in Hepatic Metabolic Regulation
Sihao Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
MBX-8025, A Novel Peroxisome Proliferator Receptor-δ Agonist: Lipid and Other Metabolic Effects in Dyslipidemic Overweight Patients Treated with and without Atorvastatin
Harold E. Bays et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Obesity 1 The global obesity pandemic: shaped by global drivers and local environments
Boyd A. Swinburn et al.
LANCET (2011)
Moculation of macrophage efferocytosis in inflammation
Darlynn Korns et al.
FRONTIERS IN IMMUNOLOGY (2011)
Activation of Peroxisome Proliferator-Activated Receptor-δ by GW501516 Prevents Fatty Acid-Induced Nuclear Factor-κB Activation and Insulin Resistance in Skeletal Muscle Cells
Teresa Coll et al.
ENDOCRINOLOGY (2010)
Substrate Fate in Activated Macrophages: A Comparison between Innate, Classic, and Alternative Activation
Juan-Carlos Rodriguez-Prados et al.
JOURNAL OF IMMUNOLOGY (2010)
PPARδ is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction
Kim Ravnskjaer et al.
JOURNAL OF LIPID RESEARCH (2010)
Transcriptional profiling reveals divergent roles of PPARα and PPARβ/δ in regulation of gene expression in mouse liver
Linda M. Sanderson et al.
PHYSIOLOGICAL GENOMICS (2010)
PPARδ Agonism Activates Fatty Acid Oxidation via PGC-1α but Does Not Increase Mitochondrial Gene Expression and Function
Sandra Kleiner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Circulating Fibroblast Growth Factor 21 Is Induced by Peroxisome Proliferator-Activated Receptor Agonists But Not Ketosis in Man
Constantinos Christodoulides et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux
Carlos L. J. Vrins et al.
JOURNAL OF LIPID RESEARCH (2009)
PPAR-δ senses and orchestrates clearance of apoptotic cells to promote tolerance
Lata Mukundan et al.
NATURE MEDICINE (2009)
Emerging roles of peroxisome proliferator-activated receptor-β/δ in inflammation
David Bishop-Bailey et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity
Kihwa Kang et al.
CELL METABOLISM (2008)
Alternative M2 activation of Kupffer cells by PPARδ ameliorates obesity-induced insulin resistance
Justin I. Odegaard et al.
CELL METABOLISM (2008)
Activation of peroxisome proliferator-activated receptor β/δ inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-κB activity via extracellular signal-related kinase 1/2
Ricardo Rodriguez-Calvo et al.
DIABETES (2008)
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home
Andrew N. Billin
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Peroxisome proliferator-activated receptor-δ induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice
Xiaomei Qin et al.
HEPATOLOGY (2008)
Insulin sensitivity: modulation by nutrients and inflammation
Simon Schenk et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Ligand Activation of Peroxisome Proliferator-Activated Receptor-β/δ Inhibits Cell Proliferation in Human HaCaT Keratinocytes
Michael G. Borland et al.
MOLECULAR PHARMACOLOGY (2008)
Ligand-Mediated Regulation of Peroxisome Proliferator-Activated Receptor (PPAR) β/δ: A Comparative Analysis of PPAR-Selective Agonists and All-trans Retinoic Acid
Markus Rieck et al.
MOLECULAR PHARMACOLOGY (2008)
It's Not How Fat You Are, It's What You Do with It That Counts.
Samuel Virtue et al.
PLOS BIOLOGY (2008)
Activation of peroxisome proliferator-activated receptor (PPAR)δ promotes reversal of multiple metabolic abnormalities, reduces oxidative stress, and increases fatly acid oxidation in moderately obese men
Ulf Riserus et al.
DIABETES (2008)
Adipose tissue distribution and quantification of PPARβ/δ and PPARγ1-3 mRNAs:: Discordant gene expression in subcutaneous, retroperitoneal and visceral adipose tissue of morbidly obese patients
Josiane Woutheres Bortolotto et al.
OBESITY SURGERY (2007)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
Triglyceride:: High-density lipoprotein cholesterol effects in healthy subjects administered a peroxisome proliferator activated receptor δ agonist
Dennis L. Sprecher et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Abdominal obesity and metabolic syndrome
Jean-Pierre Despres et al.
NATURE (2006)
Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation
Divya Vats et al.
CELL METABOLISM (2006)
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
T Nagasawa et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem
SB Wyatt et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2006)
PPARδ regulates glucose metabolism and insulin sensitivity
CH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Reduced cholesterol absorption upon PPARδ activation coincides with decreased intestinal expression of NPC1L1
JN van der Veen et al.
JOURNAL OF LIPID RESEARCH (2005)
Activation of nuclear hormone receptor peroxisome proliferator-activated receptor-δ accelerates intestinal adenoma growth
RA Gupta et al.
NATURE MEDICINE (2004)
Regulation of muscle fiber type and running endurance by PPARδ
YX Wang et al.
PLOS BIOLOGY (2004)
Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome
T Tanaka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes
JJ Senn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity
YX Wang et al.
CELL (2003)
Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer
Y Barak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
WR Oliver et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Peroxisome proliferator-activated receptor δ (PPhRδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling
JB Hansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Alterations of peroxisome proliferator-activated receptor δ activity affect fatty acid-controlled adipose differentiation
C Bastie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Activation of PPARδ alters lipid metabolism in db/db mice
MD Leibowitz et al.
FEBS LETTERS (2000)
分享论文
